[Antagonists in neonatal sepsis].
Mancilla-Ramírez
J
J
Ramírez-Herrera
M
M
Portillo-Gómez
L
L
Gaitán-Meza
J
J
Dinarello
C A
CA
D000209:Acute-Phase Proteins / Q000276:immunology; D000818:Animals; D000831:Animals, Newborn; D001424:Bacterial Infections / Q000276:immunology*; D002352:Carrier Proteins / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000276:immunology / Q000627:therapeutic use; D008562:Membrane Glycoproteins; D051381:Rats; D012795:Sialoglycoproteins / Q000276:immunology / Q000627:therapeutic use; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D008562:Membrane Glycoproteins; D012795:Sialoglycoproteins; D000099231:Lipopolysaccharide-Binding Protein; C507763:IL1RN protein, human